Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Bar-Or

Showing results (31-40 of 409) with videos related to

Pageof 41
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2004
Distinct profiles of human B cell effector cytokines: a role in immune regulation?Martin E Duddy, Andrea Alter, Amit Bar-Or
Nature Immunology|June 22, 2018
Reassessing B cell contributions in multiple sclerosisRui Li, Kristina R Patterson, Amit Bar-Or
Frontiers in Immunology|October 26, 2020
Editorial: Update on Translational Neuroimmunology - Research of ISNI 2018Lesley Probert, Francisco J Quintana, Amit Bar-Or
Journal of Neuroimmunology|April 3, 2007
8th international congress of neuroimmunologyJack Antel, Amit Bar-Or, Ralf Gold, et al.
Annals of Neurology|March 28, 2015
Considering a career in neurology research? Heed these wordsFrances E Jensen, Henry L Paulson, Amit Bar-Or
Acta Neuropathologica|January 22, 2015
High CCR5 expression in natalizumab-associated progressive multifocal leukoencephalopathy immune reconstitution inflammatory syndrome supports treatment with the CCR5 inhibitor maravirocLidia Stork, Wolfgang Brück, Amit Bar-Or, et al.
Expert Review of Neurotherapeutics|August 26, 2011
Harnessing the therapeutic potential of mesenchymal stem cells in multiple sclerosisPeter J Darlington, Marie-Noëlle Boivin, Amit Bar-Or
Annals of Clinical and Translational Neurology|September 25, 2015
Sequencing the immunopathologic heterogeneity in multiple sclerosisJack P Antel, Samuel K Ludwin, Amit Bar-Or
Current Opinion in Neurology|May 13, 2009
Emerging multiple sclerosis disease-modifying therapiesPaul S Giacomini, Peter J Darlington, Amit Bar-Or
CNS Drugs|August 30, 2011
Targeting progressive neuroaxonal injury: lessons from multiple sclerosisAmit Bar-Or, Peter Rieckmann, Anthony Traboulsee, et al.
Pageof 41

Showing results (31-40 of 409) with videos related to

Sort By:
Pageof 41
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2004
Distinct profiles of human B cell effector cytokines: a role in immune regulation?Martin E Duddy, Andrea Alter, Amit Bar-Or
Nature Immunology|June 22, 2018
Reassessing B cell contributions in multiple sclerosisRui Li, Kristina R Patterson, Amit Bar-Or
Frontiers in Immunology|October 26, 2020
Editorial: Update on Translational Neuroimmunology - Research of ISNI 2018Lesley Probert, Francisco J Quintana, Amit Bar-Or
Journal of Neuroimmunology|April 3, 2007
8th international congress of neuroimmunologyJack Antel, Amit Bar-Or, Ralf Gold, et al.
Annals of Neurology|March 28, 2015
Considering a career in neurology research? Heed these wordsFrances E Jensen, Henry L Paulson, Amit Bar-Or
Acta Neuropathologica|January 22, 2015
High CCR5 expression in natalizumab-associated progressive multifocal leukoencephalopathy immune reconstitution inflammatory syndrome supports treatment with the CCR5 inhibitor maravirocLidia Stork, Wolfgang Brück, Amit Bar-Or, et al.
Expert Review of Neurotherapeutics|August 26, 2011
Harnessing the therapeutic potential of mesenchymal stem cells in multiple sclerosisPeter J Darlington, Marie-Noëlle Boivin, Amit Bar-Or
Annals of Clinical and Translational Neurology|September 25, 2015
Sequencing the immunopathologic heterogeneity in multiple sclerosisJack P Antel, Samuel K Ludwin, Amit Bar-Or
Current Opinion in Neurology|May 13, 2009
Emerging multiple sclerosis disease-modifying therapiesPaul S Giacomini, Peter J Darlington, Amit Bar-Or
CNS Drugs|August 30, 2011
Targeting progressive neuroaxonal injury: lessons from multiple sclerosisAmit Bar-Or, Peter Rieckmann, Anthony Traboulsee, et al.
Pageof 41